WELLS FARGO & COMPANY/MN - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$84,167
-32.0%
5,327
-34.9%
0.00%
Q2 2023$123,845
+4952.8%
8,180
+4740.2%
0.00%
Q1 2023$2,451
+7.9%
169
+0.6%
0.00%
Q4 2022$2,271
-24.3%
168
+1.8%
0.00%
Q3 2022$3,000
+50.0%
165
+46.0%
0.00%
Q2 2022$2,000
-90.5%
113
-95.1%
0.00%
Q1 2022$21,000
-76.9%
2,285
-57.0%
0.00%
Q4 2021$91,0005,3200.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$64,173,86826.74%
5AM Venture Management, LLC 4,408,379$63,921,49616.35%
72 Investment Holdings, LLC 509,023$7,380,8333.50%
StepStone Group LP 761,277$11,038,5172.05%
TCG Crossover Management, LLC 584,955$8,481,8481.65%
Redmile Group, LLC 1,831,608$26,558,3161.15%
Nan Fung Group Holdings Ltd 73,582$1,066,9390.73%
Baker Brothers Advisors 4,865,819$70,554,3760.38%
CHI Advisors LLC 56,374$817,4230.22%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,522,5000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders